Opaleye Management Inc. - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 41 filers reported holding LUMOS PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2022$412,000
+148.2%
46,576
+116.4%
0.17%
+126.7%
Q2 2022$166,000
-95.7%
21,520
-94.4%
0.08%
-88.2%
Q2 2021$3,820,000
-13.4%
382,000
+1.4%
0.63%
-2.2%
Q1 2021$4,410,000
-56.1%
376,900
+34.0%
0.65%
-50.6%
Q4 2020$10,045,000
+201.7%
281,287
+16.8%
1.31%
+101.5%
Q3 2020$3,329,000240,8920.65%
Other shareholders
LUMOS PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Acuitas Investments, LLC 153,867$507,7610.30%
Lion Point Capital, LP 78,351$258,5580.12%
Minerva Advisors LLC 26,549$840.06%
Wealth Advisors of Iowa, LLC 11,699$38,6060.03%
Marquette Asset Management, LLC 31,088$102,5910.02%
Greenwich Wealth Management LLC 49,002$1620.02%
Key FInancial Inc 10,927$36,0590.01%
Paladin Advisory Group, LLC 4,387$14,4770.01%
Blackstone Inc. 468,145$1,544,8790.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$157,2220.00%
View complete list of LUMOS PHARMA INC shareholders